Cleveland Clinic Cancer Center (Taussig) Outcomes
Gynecologic Oncology
Ovarian Cancer
Optimal Cytoreduction Rates in Patients With Stages I-IIIC Ovarian Cancerᵃ (N = 618)
2011-2021
ᵃIncludes patients treated at main campus, Cleveland Clinic Family Health Centers, Fairview Hospital and Hillcrest Hospital.
Cleveland Clinic's performance was 58.1% (359 of 618 patients) from 2011-2021 for patients receiving Salping-oophorectomy with omenectomy, debulking; cytoreductive surgery; or pelvic exteneration in stages I-IIIC ovarian cancer.